EAU 2013 - Programme Book - YouMed

Monday, 18 March - EAU Programme
Abstract Session
09.15 - 10.45 Urothelial cancer treatment: Predicting outcomes
Red Hall 1 - Level N1
Poster Session 62
Chairs: S.F. Shariat, New York (US)
R. Sosnowski, Warsaw (PL)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion.
748 Clinical impact of grade on both recurrence and progression in T1 bladder cancer: Comparison between
WHO 1973 and WHO 2004 histological classification
F. Pellucchi, L. Rocchini, C. Maccagnano, G. Zanni, G. La Croce, M. Moschini, M. Bianchi, P. Rigatti,
R. Colombo (Milan, Italy)
749 Clinical outcome in patients with T1 micropapillary carcinoma of the bladder
M. Spaliviero, G. Dalbagni, B.H. Bochner, B.Y. Poon, T.F. Donahue, H.A. Al-Ahmadie, J.M. Taylor, J.J. Meeks,
D.D. Sjoberg, S.M. Donat, H.W. Herr (New York, United States of America)
750 Leucocyte infiltration is a prognostic factor in bladder cancer stage T1
O. Patschan, P.O. Bendahl, G. Chebil, H. Engilbertsson, S. Gudjonsson, P. Kollberg, F. Liedberg (Malmö,
Lund, Helsingborg, Sweden)
751 T1 urinary bladder cancer - long time observation population-based material
S. Jahnson, S. Holmang, F. Liedberg, B Ljungberg, A. Hosseini-Aliabad (Linköping, Gothenburg, Malmö,
Umeå, Stockholm, Sweden)
752 Female gender is associated with higher risk of disease recurrence in patients with primary T1 high grade
urothelial carcinoma of the bladder
L.A. Kluth, E. Xylinas, J.J. Crivelli, H. Fajkovic, N. Passoni, M. Rouprêt, A. Becker, E. Comploj, A. Pycha,
S. Holmang, A. Gupta, Y. Lotan, P.I. Karakiewicz, P. Gontero, F.K.H. Chun, M. Fisch, D.S. Scherr, S. Shariat
(New York, Iowa City, Dallas, United States of America; St.Poelten, Austria; Milan, Bolzano, Turin, Italy;
Paris, France; Montreal, Canada; Gothenburg, Sweden; Hamburg, Germany)
753 Oncological outcome of radical cystectomy for BCG failure compared to primary invasive disease
A. Masson-Lecomte, D. Vordos, R. Yiou, Y. Allory, C.C. Abbou, A. De La Taille, L. Salomon (Creteil, France)
754 Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non muscleinvasive
urothelial carcinoma of the bladder
E.N. Xylinas, M. Kent, L.A. Kluth, D. Sjoberg, A. Pycha, E. Comploj, Y. Lotan, R.S. Svatek, Q.D. Trinh,
P.I. Karakiewicz, S. Holmang, D.S. Scherr, M. Zerbib, S.F. Shariat (New York, Dallas, United States of
America; Bolzano, Italy; Montreal, Canada; Gothenburg, Sweden; Paris, France)
755 Prediction of recurrence probabilities after intravesical treatment in patients with non-muscle-invasive
bladder cancer
R.J.M. Lammers, J.C.M. Hendriks, J. Palou, W.P.J. Witjes, J.A. Witjes (Nijmegen, Arnhem, The Netherlands;
Barcelona, Spain)
756 Prediction of progression in patients with non-muscle invasive bladder cancer based on histologic grade, T
stage, recurrence rate and bladder neck involvement: The BN-GTR model
Y. Fujii, S. Kobayashi, F. Koga, M. Yokoyama, S. Yoshida, J. Ishioka, Y. Matsuoka, N. Numao, K. Saito,
H. Masuda, K. Kihara (Tokyo, Japan)
EAU Milan 2013
247
Monday